anmelden
SMI Expanded
1.972,28
PKT
-10,97
PKT
-0,55
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI Expanded-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 06.10.22 | UBS Hold | Deutsche Bank AG | |
| 06.10.22 | Nestlé Overweight | Barclays Capital | |
| 06.10.22 | UBS Neutral | JP Morgan Chase & Co. | |
| 05.10.22 | DocMorris Hold | Deutsche Bank AG | |
| 05.10.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.10.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.10.22 | Richemont Overweight | Barclays Capital | |
| 04.10.22 | Roche Hold | Deutsche Bank AG | |
| 04.10.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 04.10.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.10.22 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 03.10.22 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 03.10.22 | UBS Hold | Jefferies & Company Inc. | |
| 03.10.22 | UBS Sector Perform | RBC Capital Markets | |
| 03.10.22 | UBS Outperform | RBC Capital Markets | |
| 03.10.22 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
| 03.10.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 03.10.22 | UBS Underweight | JP Morgan Chase & Co. | |
| 03.10.22 | Richemont Buy | UBS AG | |
| 30.09.22 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 30.09.22 | Clariant Outperform | Credit Suisse Group | |
| 30.09.22 | Richemont Overweight | JP Morgan Chase & Co. | |
| 29.09.22 | Roche Neutral | UBS AG | |
| 29.09.22 | Roche Hold | Deutsche Bank AG | |
| 29.09.22 | Roche Overweight | Barclays Capital | |
| 29.09.22 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 28.09.22 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 28.09.22 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
| 28.09.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 28.09.22 | Givaudan Sell | UBS AG | |
| 28.09.22 | Givaudan Hold | Deutsche Bank AG | |
| 28.09.22 | Roche Hold | Deutsche Bank AG | |
| 28.09.22 | Swiss Re Outperform | Credit Suisse Group | |
| 27.09.22 | Richemont Market-Perform | Bernstein Research | |
| 27.09.22 | Zurich Insurance Overweight | JP Morgan Chase & Co. | |
| 27.09.22 | DocMorris Equal Weight | Barclays Capital | |
| 26.09.22 | Novartis Neutral | UBS AG | |
| 26.09.22 | Nestlé Underperform | Jefferies & Company Inc. | |
| 23.09.22 | Novartis Sell | Deutsche Bank AG | |
| 23.09.22 | UBS Neutral | UBS AG |
